Fundz

Fundz Deep Dive

Everything you need to win University Medical Center Groningen (UMCG) and SHINE Europe — in one platform.

Who to reach, what to say, and why now on University Medical Center Groningen (UMCG) and SHINE Europe — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on University Medical Center Groningen (UMCG) and SHINE Europe — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

UMCG and SHINE Europe Receive €10.5 Million Grant to Advance European Terbium Isotope Production for Cancer Theranostics

Oct 17, 2024•over 1 year ago

Contract Type

partnership

ManufacturingHealth Care

Description

University Medical Center Groningen (UMCG) and SHINE Europe have announced receiving a €10.5 million grant from the Dutch government for the Terbium for Life project. The initiative aims to bolster Europe's cancer treatment capabilities and enhance supply chain security within the European Medical Isotope market.

Company Information

Company

University Medical Center Groningen (UMCG) and SHINE Europe

About

University Medical Center Groningen (UMCG) is a leading medical center in the Netherlands. SHINE Europe is a company specializing in isotope production and supply chain security.

Predictive Intelligence
Strategic

ML-powered predictions for University Medical Center Groningen (UMCG) and SHINE Europe's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.